Ted W Love's Net Worth

$45.2 Million

Estimate Recalculated Sep 17, 2024 01:31PM EST

Who is Ted W Love?

Ted W Love has an estimated net worth of $45.2 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, Oncothyreon Inc., Royalty Pharma plc, BIO RAD LABORATORIES INC, Structure Therapeutics Inc., AMICUS THERAPEUTICS INC, Global Blood Therapeutics, Inc., KALOBIOS PHARMACEUTICALS INC, ADVENTRX PHARMACEUTICALS INC, NUVELO INC, AFFYMAX INC, SANTARUS INC, ONYX PHARMACEUTICALS INC, PORTOLA PHARMACEUTICALS INC, and GILEAD SCIENCES, INC..

SEC CIK

Ted W Love's CIK is 0001188919

Past Insider Trading and Trends

2012 was Ted W Love's most active year for acquiring shares with 14 total transactions. Ted W Love's most active month to acquire stocks was the month of May. 2022 was Ted W Love's most active year for disposing of shares, totalling 28 transactions. Ted W Love's most active month to dispose stocks was the month of July. 2012 saw Ted W Love paying a total of $2,332,575.00 for 521,716 shares, this is the most they've acquired in one year. In 2014 Ted W Love cashed out on 573,000 shares for a total of $16,547,365.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Seagen Inc. (SGEN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.25K
$229.00
-$974,395.00
0
Dec 14
Form 4
+43.45%
2.04K
—
—
6.75K
May 31
Form 4
+46.95%
1.5K
—
—
4.7K
May 13
Form 4
+77.93%
1.4K
—
—
3.2K
May 14
Form 4
∞
1.8K
—
—
1.8K
Aug 17
Form 3
—
0
—
—
0
No matching records found

Cascadian Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-37.39K
—
—
0
Mar 9
Form 4
+5.00%
1.78K
$3.94
-$2,340.36
37.39K
Sep 24
Form 4
+23.57%
6.79K
$3.78
-$8,561.70
35.61K
Jun 24
Form 4
+5.92%
1.61K
$3.34
-$1,793.58
28.82K
Jun 9 - Jun 12
Form 4
+546.45%
23K
$4.24
$97,520.00
27.21K
Feb 2
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Sep 24
Form 4
∞
13.01K
$3.25
-$14,092.00
13.01K
Sep 5
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Sep 5
Form 3
—
0
—
—
0
No matching records found

Royalty Pharma plc (RPRX) Snapshot price: $28.72

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25.16%
9.29K
—
—
46.23K
Jun 7
Form 4
+26.54%
7.75K
—
—
36.94K
Jun 23
Form 4
+27.67%
6.33K
—
—
29.19K
Jun 24
Form 4
+33.41%
5.73K
—
—
22.87K
Jun 25
Form 4
+72.80%
7.28K
—
—
17.28K
Aug 13
Form 3
—
0
—
—
0
No matching records found

BIO RAD LABORATORIES INC (BIO) Snapshot price: $329.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Structure Therapeutics Inc. (GPCR) Snapshot price: $36.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Aug 3
Form 3
—
0
—
—
0
No matching records found